The purpose of this study was to evaluate the impact of changes to a patient's prandial status, metabolic status (rest vs. exercise), and peripheral blood flow (via caffeine or warming) on the uptake of (99m)Tc-sestamibi in breast tissue.
Methods: A total of 154 subjects participated in 1 of 4 study groups that evaluated the effects of 4 types of intervention on the uptake of (99m)Tc-sestamibi in breast tissue (effect of fasting, light exercise, caffeine, and peripheral warming). Molecular breast imaging was performed before and after each intervention. Count density was assessed in counts/cm(2)/MBq from the mediolateral oblique view in all studies.
Results: Uptake of (99m)Tc-sestamibi in breast tissue increased by approximately 25% from 6.6 counts/cm(2)/MBq in the fed state to 8.3 counts/cm(2)/MBq with fasting. Peripheral warming also resulted in an approximately 20% increase in count density from 9.1 to 10.9 counts/cm(2)/MBq. Conversely, exercise caused a 35% drop in count density relative to the resting state. Uptake did not seem to be influenced by caffeine and did not correlate with a patient's height, weight, or breast thickness. There was only a weak correlation between breast activity and body surface area.
Conclusion: The combined effects of fasting and warming resulted in an approximately 50% increased uptake of (99m)Tc-sestamibi in breast tissue relative to that observed in a reference group to whom no preparatory instructions had been given. Optimal patient preparation before administration of (99m)Tc-sestamibi should permit a corresponding reduction in either acquisition time or required dose of (99m)Tc-sestamibi.
Trial registration: ClinicalTrials.gov NCT01944215.
Keywords: 99mTc-sestamibi; breast; exercise; fasting.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.